A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
From his beginnings at DuPont Merck to his current position as Cybin’s (NYSE:CYBN) CEO, Doug Drysdale has certainly…
Benzinga’s Top Upgrades, Downgrades For January 22, 2020
Upgrades Citigroup changed the rating for Comerica Inc (NYSE:CMA) from Sell to Neutral. Comerica earned $1.85 in the fourth quarter, compared…
Ironwood And Allergan Announce Settlement With Teva Resolving LINZESS Patent Litigation; Settlement Does Not Grant License To Teva With Regard To 72 mcg Generic Version Of LINZESS, Grants Teva License To Market 145 mcg And 290 mcg Generics Starting 202…
– Settlement with Teva represents final outstanding LINZESS patent litigation – – The earliest licensed entry of any…
Wells Fargo Downgrades Allergan to Equal-Weight, Announces $198 Price Target
Wells Fargo analyst David Maris downgrades Allergan (NYSE:AGN) from Overweight to Equal-Weight and announces $198 price target.